(4-(Trifluoromethyl)pyridin-2-yl)boronic Acid (cas# 870459-90-8) is used in synthesis of N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide derivatives, which can be used in the treatment of a CFTR-mediated disease.
參考文獻
Azimioara, M., et. al.: PCT Int. Appl., 285pp. (2020)